DaVita Inc. (0I7E.L)
USD 140.53
(-0.62%)
USD 140.53
(-0.62%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 691.53 Million USD | -9.98% |
| 2022 | 768.19 Million USD | -21.49% |
| 2021 | 978.45 Million USD | 26.47% |
| 2020 | 773.64 Million USD | -4.6% |
| 2019 | 810.98 Million USD | 2.65% |
| 2018 | 790.07 Million USD | 19.06% |
| 2017 | 663.61 Million USD | -24.58% |
| 2016 | 879.87 Million USD | 226.2% |
| 2015 | 269.73 Million USD | -62.7% |
| 2014 | 723.11 Million USD | 14.16% |
| 2013 | 633.44 Million USD | 18.18% |
| 2012 | 536.01 Million USD | 12.14% |
| 2011 | 478 Million USD | 17.83% |
| 2010 | 405.68 Million USD | -4.02% |
| 2009 | 422.68 Million USD | 12.97% |
| 2008 | 374.16 Million USD | -2.0% |
| 2007 | 381.77 Million USD | 31.79% |
| 2006 | 289.69 Million USD | 26.7% |
| 2005 | 228.64 Million USD | 2.87% |
| 2004 | 222.25 Million USD | 26.43% |
| 2003 | 175.79 Million USD | 11.73% |
| 2002 | 157.32 Million USD | 14.58% |
| 2001 | 137.31 Million USD | 918.28% |
| 2000 | 13.48 Million USD | 109.16% |
| 1999 | -147.25 Million USD | -3324.56% |
| 1998 | -4.3 Million USD | -111.62% |
| 1997 | 37 Million USD | 131.25% |
| 1996 | 16 Million USD | 75.82% |
| 1995 | 9.1 Million USD | 85.71% |
| 1994 | 4.9 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 239.64 Million USD | 59.06% |
| 2024 Q3 | 214.68 Million USD | -3.59% |
| 2024 Q2 | 222.67 Million USD | -7.08% |
| 2023 Q1 | 170.66 Million USD | 50.82% |
| 2023 Q3 | 246.63 Million USD | 38.02% |
| 2023 Q4 | 150.66 Million USD | -38.91% |
| 2023 FY | 691.53 Million USD | -9.98% |
| 2023 Q2 | 178.69 Million USD | 4.7% |
| 2022 Q2 | 224.8 Million USD | 38.67% |
| 2022 Q1 | 162.12 Million USD | -13.52% |
| 2022 FY | 768.19 Million USD | -21.49% |
| 2022 Q3 | 164.69 Million USD | -26.74% |
| 2022 Q4 | 113.16 Million USD | -31.29% |
| 2021 Q2 | 293.82 Million USD | 23.76% |
| 2021 Q1 | 237.4 Million USD | 36.62% |
| 2021 Q3 | 259.75 Million USD | -11.59% |
| 2021 Q4 | 187.47 Million USD | -27.83% |
| 2021 FY | 978.45 Million USD | 26.47% |
| 2020 Q3 | 158.67 Million USD | -21.29% |
| 2020 FY | 773.64 Million USD | -4.6% |
| 2020 Q2 | 201.6 Million USD | -15.86% |
| 2020 Q1 | 239.59 Million USD | -2.16% |
| 2020 Q4 | 173.77 Million USD | 9.52% |
| 2019 FY | 810.98 Million USD | 2.65% |
| 2019 Q2 | 273.55 Million USD | 83.24% |
| 2019 Q4 | 244.87 Million USD | 70.92% |
| 2019 Q1 | 149.28 Million USD | 199.68% |
| 2019 Q3 | 143.27 Million USD | -47.63% |
| 2018 Q1 | 178.68 Million USD | -41.1% |
| 2018 Q4 | -149.77 Million USD | -9.49% |
| 2018 Q2 | 267.17 Million USD | 49.52% |
| 2018 Q3 | -136.79 Million USD | -151.2% |
| 2018 FY | 790.07 Million USD | 19.06% |
| 2017 Q4 | 303.39 Million USD | 241.46% |
| 2017 Q3 | -214.47 Million USD | -268.88% |
| 2017 FY | 663.61 Million USD | -24.58% |
| 2017 Q1 | 447.69 Million USD | 183.84% |
| 2017 Q2 | 127 Million USD | -71.63% |
| 2016 Q1 | 97.43 Million USD | 1723.9% |
| 2016 Q4 | 157.72 Million USD | -72.39% |
| 2016 Q3 | 571.33 Million USD | 970.27% |
| 2016 FY | 879.87 Million USD | 226.2% |
| 2016 Q2 | 53.38 Million USD | -45.21% |
| 2015 Q3 | 215.87 Million USD | 26.63% |
| 2015 Q2 | 170.47 Million USD | 254.11% |
| 2015 Q1 | -110.61 Million USD | -153.18% |
| 2015 FY | 269.73 Million USD | -62.7% |
| 2015 Q4 | -6 Million USD | -102.78% |
| 2014 Q3 | 184.12 Million USD | 24.67% |
| 2014 Q1 | 183.28 Million USD | -13.66% |
| 2014 Q4 | 208.02 Million USD | 12.98% |
| 2014 FY | 723.11 Million USD | 14.16% |
| 2014 Q2 | 147.68 Million USD | -19.43% |
| 2013 FY | 633.44 Million USD | 18.18% |
| 2013 Q4 | 212.27 Million USD | 55.37% |
| 2013 Q3 | 136.62 Million USD | -46.29% |
| 2013 Q2 | 254.37 Million USD | 743.31% |
| 2013 Q1 | 30.16 Million USD | -80.64% |
| 2012 Q3 | 144.72 Million USD | 51.8% |
| 2012 Q1 | 140.12 Million USD | -5.4% |
| 2012 Q2 | 95.33 Million USD | -31.96% |
| 2012 Q4 | 155.83 Million USD | 7.68% |
| 2012 FY | 536.01 Million USD | 12.14% |
| 2011 Q2 | 100.01 Million USD | 5.83% |
| 2011 Q4 | 148.12 Million USD | 9.43% |
| 2011 FY | 478 Million USD | 17.83% |
| 2011 Q1 | 94.5 Million USD | 36.92% |
| 2011 Q3 | 135.36 Million USD | 35.34% |
| 2010 FY | 405.68 Million USD | -4.02% |
| 2010 Q4 | 69.02 Million USD | -42.19% |
| 2010 Q3 | 119.38 Million USD | 10.69% |
| 2010 Q2 | 107.85 Million USD | -1.43% |
| 2010 Q1 | 109.42 Million USD | -0.27% |
| 2009 FY | 422.68 Million USD | 12.97% |
| 2009 Q4 | 109.72 Million USD | -1.09% |
| 2009 Q3 | 110.93 Million USD | 4.83% |
| 2009 Q2 | 105.81 Million USD | 9.99% |
| 2009 Q1 | 96.21 Million USD | -2.19% |
| 2008 Q2 | 94.95 Million USD | 9.22% |
| 2008 Q1 | 86.93 Million USD | 1.42% |
| 2008 FY | 374.16 Million USD | -2.0% |
| 2008 Q4 | 98.36 Million USD | 4.74% |
| 2008 Q3 | 93.91 Million USD | -1.1% |
| 2007 Q1 | 76.58 Million USD | 3.31% |
| 2007 Q4 | 85.71 Million USD | -9.25% |
| 2007 Q3 | 94.45 Million USD | -24.45% |
| 2007 Q2 | 125.02 Million USD | 63.26% |
| 2007 FY | 381.77 Million USD | 31.79% |
| 2006 FY | 289.69 Million USD | 26.7% |
| 2006 Q4 | 74.12 Million USD | -21.85% |
| 2006 Q3 | 94.85 Million USD | 50.0% |
| 2006 Q2 | 63.23 Million USD | 10.04% |
| 2006 Q1 | 57.46 Million USD | -10.41% |
| 2005 Q2 | 52.94 Million USD | -6.02% |
| 2005 FY | 228.64 Million USD | 2.87% |
| 2005 Q4 | 64.14 Million USD | 16.18% |
| 2005 Q3 | 55.21 Million USD | 4.3% |
| 2005 Q1 | 56.33 Million USD | -0.47% |
| 2004 FY | 222.25 Million USD | 26.43% |
| 2004 Q4 | 56.6 Million USD | -6.27% |
| 2004 Q3 | 60.38 Million USD | 15.24% |
| 2004 Q2 | 52.4 Million USD | -0.88% |
| 2004 Q1 | 52.86 Million USD | -15.82% |
| 2003 Q3 | 38.06 Million USD | -1.19% |
| 2003 Q2 | 38.52 Million USD | 5.79% |
| 2003 FY | 175.79 Million USD | 11.73% |
| 2003 Q1 | 36.41 Million USD | -38.08% |
| 2003 Q4 | 62.79 Million USD | 65.0% |
| 2002 Q2 | 8.37 Million USD | -76.74% |
| 2002 Q1 | 35.97 Million USD | 10.5% |
| 2002 Q3 | 54.17 Million USD | 547.19% |
| 2002 FY | 157.32 Million USD | 14.58% |
| 2002 Q4 | 58.81 Million USD | 8.57% |
| 2001 Q3 | 44.27 Million USD | 49.87% |
| 2001 FY | 137.31 Million USD | 918.28% |
| 2001 Q1 | 30.93 Million USD | 101.75% |
| 2001 Q4 | 32.55 Million USD | -26.47% |
| 2001 Q2 | 29.54 Million USD | -4.49% |
| 2000 Q4 | 15.33 Million USD | 58.73% |
| 2000 Q1 | 3.84 Million USD | 102.6% |
| 2000 Q3 | 9.66 Million USD | 162.91% |
| 2000 FY | 13.48 Million USD | 109.16% |
| 2000 Q2 | -15.35 Million USD | -499.14% |
| 1999 Q2 | -21 Million USD | -175.27% |
| 1999 FY | -147.25 Million USD | -3324.56% |
| 1999 Q1 | 27.9 Million USD | 43.81% |
| 1999 Q4 | -148.05 Million USD | -7892.42% |
| 1999 Q3 | 1.9 Million USD | 109.05% |
| 1998 Q1 | -62.4 Million USD | -700.0% |
| 1998 FY | -4.3 Million USD | -111.62% |
| 1998 Q4 | 19.4 Million USD | -33.33% |
| 1998 Q3 | 29.1 Million USD | 268.35% |
| 1998 Q2 | 7.9 Million USD | 112.66% |
| 1997 FY | 37 Million USD | 131.25% |
| 1997 Q3 | 9.9 Million USD | 11.24% |
| 1997 Q2 | 8.9 Million USD | 14.1% |
| 1997 Q1 | 7.8 Million USD | 8.33% |
| 1997 Q4 | 10.4 Million USD | 5.05% |
| 1996 Q1 | 4.3 Million USD | 53.57% |
| 1996 Q2 | 5.7 Million USD | 32.56% |
| 1996 Q3 | -1.2 Million USD | -121.05% |
| 1996 Q4 | 7.2 Million USD | 700.0% |
| 1996 FY | 16 Million USD | 75.82% |
| 1995 Q4 | 2.8 Million USD | 16.67% |
| 1995 Q3 | 2.4 Million USD | 84.62% |
| 1995 FY | 9.1 Million USD | 85.71% |
| 1995 Q2 | 1.3 Million USD | 8.33% |
| 1995 Q1 | 1.2 Million USD | 0.0% |
| 1994 Q4 | 1.2 Million USD | 0.0% |
| 1994 FY | 4.9 Million USD | 0.0% |
| 1994 Q3 | 1.2 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 605.194% |
| Accuray Incorporated | -15.54 Million USD | 4548.601% |
| Align Technology, Inc. | 445.05 Million USD | -55.383% |
| Elevance Health Inc. | 5.98 Billion USD | 88.449% |
| AxoGen, Inc. | -21.71 Million USD | 3284.449% |
| Boston Scientific Corporation | 1.59 Billion USD | 56.589% |
| CVS Health Corporation | 8.34 Billion USD | 91.712% |
| Cardinal Health, Inc. | 852 Million USD | 18.834% |
| Centene Corporation | 2.7 Billion USD | 74.407% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 86.808% |
| Hologic, Inc. | 789.5 Million USD | 12.408% |
| Humana Inc. | 2.48 Billion USD | 72.216% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 18.166% |
| Laboratory Corporation of America Holdings | 418 Million USD | -65.439% |
| Masimo Corporation | 81.5 Million USD | -748.509% |
| McKesson Corporation | 3 Billion USD | 76.964% |
| Patterson Companies, Inc. | 185.93 Million USD | -271.931% |
| Quest Diagnostics Incorporated | 854 Million USD | 19.024% |
| ResMed Inc. | 1.02 Billion USD | 32.266% |
| Henry Schein, Inc. | 416 Million USD | -66.234% |
| Teladoc Health, Inc. | -220.36 Million USD | 413.809% |
| Universal Health Services, Inc. | 717.79 Million USD | 3.658% |
| Veeva Systems Inc. | 525.7 Million USD | -31.544% |
| Baxter International Inc. | 2.65 Billion USD | 73.963% |
| Becton, Dickinson and Company | 1.48 Billion USD | 53.401% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 61.539% |
| Danaher Corporation | 4.2 Billion USD | 83.535% |
| Stryker Corporation | 3.16 Billion USD | 78.151% |
| Medtronic plc | 3.67 Billion USD | 81.188% |